Scientists from the Laboratory for Proteolytic Neuroscience at RIKEN are providing various research on Alzheimer's disease especially in the study of somatostatin, a neuropeptide that inhibits the secretion of growth hormone and could lead to the discovery of new drugs for Alzheimer's disease.
RIKEN is currently conducting bio-chemical and histological analysis of the brain using an Alzheimer's disease model mouse.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment